COMMUNIQUÉS West-GlobeNewswire

Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
29/04/2025
MEDIA RELEASE Agreement offers rights to commercialize proposed biosimilar of Yervoy®* for treatment of variety of cancer types, targeting net reference medicine sales of USD 2.5 billion[1] Henlius to develop and [...]
Invitation to the presentation of ALK’s first quarter 2025 results on Tuesday, 6 May 2025
29/04/2025
ALK (ALKB.DC / OMX: ALK B) will publish its results for the first quarter of 2025 in the morning on Tuesday, 6 May 2025. Later on the same day, the company will host a presentation for investors and analysts at 11:00 a. [...]
FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT
29/04/2025
West Palm Beach, April 29, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “ Company ”), today announced that effective 4.01pm Eastern Time, on April 28, 2025, (the “Effective Time [...]
AscellaHealth Honored as Silver Stevie® Award Winner in 2025 American Business Awards®
29/04/2025
Stevie winners will be celebrated during gala event on June 10 in New York BERWYN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions to support the specialty [...]
Axiom Medical Marks 25 Years of Advancing Workplace Safety and Health at Annual Client Summit
29/04/2025
Honors Exceptional Partners Driving Innovation in Employee Well-Being HOUSTON, TX, April 29, 2025 (GLOBE NEWSWIRE) -- Axiom Medical, a leader in occupational health and workplace injury case management solutions, [...]
Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting
29/04/2025
An exposure-outcome analysis in 72 patients with refractory non-small cell lung cancer (NSCLC) who received AFM24 at 480 mg weekly demonstrates that higher drug exposure (above median) leads to improved objective [...]
Kriya Announces Thirteen Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2025
29/04/2025
– Kriya’s platform includes fully integrated best-in-class manufacturing and research capabilities to support parallel advancement of a broad pipeline of gene therapies – – Current pipeline of gene therapies for chronic [...]
Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025
29/04/2025
Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignancies VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ( [...]
Therini Bio Announces Positive Phase 1a Trial Results Evaluating THN391 for Neurodegenerative Diseases
29/04/2025
- Novel approach to treat neurodegenerative diseases by targeting fibrin-driven neuroinflammation was well-tolerated among healthy volunteers, with a clean hematological profile - - Half-life supports once-monthly [...]
Instinct Science Sponsors NOMV's Race Around the World to Support Veterinary Mental Health
29/04/2025
PHILADELPHIA, April 29, 2025 (GLOBE NEWSWIRE) -- Not One More Vet ( NOMV ), the leading nonprofit focused on mental health in veterinary medicine, is kicking off its annual Race Around the World on May 1. The monthlong [...]
Acentra Health Awarded $27.5 Million Contract from California Medicaid to Continue Providing Preadmission Screening and Resident Review (PASRR) Services
29/04/2025
Award follows new contracts in Kansas and Washington and expands the company’s PASRR services for long-term care assessments to eight states MCLEAN, Va., April 29, 2025 (GLOBE NEWSWIRE) -- Acentra Health , a technology [...]
Fate Therapeutics Announces Five Presentations on Off-the-Shelf CAR T-cell Product Platform at ASGCT Annual Meeting
29/04/2025
Updated clinical and preclinical data showcase iPSC-derived off-the-shelf CAR T-cell therapy products for conditioning chemotherapy-free treatment across autoimmune and cancer indications SAN DIEGO, April 29, 2025 ( [...]
FibroBiologics Presents at the ThymUS 2025 Meeting
29/04/2025
HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on the development of [...]
Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting
29/04/2025
Combination treatment of TFF2 with anti-PD1 antibody was associated with the activation of cancer-killing CD8+ T Cells and limiting immune evasion by tumor cells TNX-1700 is in preclinical development for gastric and [...]
WeightWatchers Streamlines Member Access to Zepbound® Vials with LillyDirect® Pharmacy Provider
29/04/2025
New Integration with Gifthealth Simplifies Fulfillment and Medication Visibility for WeightWatchers Clinic Members NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the [...]
Best Probiotics For Weight Loss: Top Rated Probiotic Supplements For Belly Fat & Menopause Women Over 50 – WOLFSON BRANDS (UK) LIMITED
29/04/2025
Looking for the best probiotics to support weight loss, target stubborn belly fat, and help manage menopause changes? Glasgow, April 29, 2025 (GLOBE NEWSWIRE) -- Whenever there is a reference to health or well-being, [...]
Best Legal Steroids for Muscle Growth, Fat Loss, and Strength: Top Natural Alternatives to Anabolic Steroids For Sale (By CrazyBulk)
29/04/2025
Discover the safest, most effective legal steroid alternatives for muscle building, fat loss, and peak strength. Backed by science, CrazyBulk’s natural formulas redefine performance without dangerous side effects. New [...]
USA Today Names HealthEquity to its Top 25 Workplaces
29/04/2025
The HSA leader was recognized for its remote-first flexibility and mental health resources, marking its fourth year on the list DRAPER, Utah, April 29, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (" [...]
Four-year Follow-up Data on SPRINT® PNS for Low Back Pain Highlights Sustained Pain Relief Avoiding Costly and Invasive Treatments
29/04/2025
CLEVELAND, April 29, 2025 (GLOBE NEWSWIRE) -- SPR announced the publication of long-term follow-up survey data from a prospective, multicenter study that demonstrated significant and sustained pain relief more than four [...]

Pages